Cargando…

JAK2 Mutations Are Rare and Diverse in Myelodysplastic Syndromes: Case Series and Review of the Literature

Objectives: To investigate and characterize JAK2 mutations in myelodysplastic syndrome (MDS), we present three cases with diverse JAK2 mutations and review the literature. Methods: The institutional SoftPath software was used to find MDS cases between January 2020 and April 2022. The cases with a di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delio, Melissa, Bryke, Christine, Mendez, Lourdes, Joseph, Loren, Jassim, Sarmad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944460/ https://www.ncbi.nlm.nih.gov/pubmed/36810551 http://dx.doi.org/10.3390/hematolrep15010008

Ejemplares similares

JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia
por: Jekarl, Dong Wook, et al.
Publicado: (2010)

Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes
por: Brecqueville, M, et al.
Publicado: (2011)

Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes
por: Machado-Neto, João Agostinho, et al.
Publicado: (2011)

Rare Cytogenetic Abnormalities in Myelodysplastic Syndromes
por: Bacher, Ulrike, et al.
Publicado: (2015)

Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome
por: Fang, Ying, et al.
Publicado: (2021)

JAK2-negative acute monocytic leukemia with TET2 mutation in essential thrombocythemia with JAK2 mutation with literature review
por: Ogasawara, Toshie, et al.
Publicado: (2020)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
por: Malcovati, Luca, et al.
Publicado: (2011)

A Rare Case of Myelodysplastic Syndrome with Refractory Thrombocytopenia
por: Jehangir, Waqas, et al.
Publicado: (2015)

The implication of identifying JAK2(V617F) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis
por: Olsen, Randall J., et al.
Publicado: (2008)

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Chesnais, Virginie, et al.
Publicado: (2012)

Mutation Analysis of the WT1 Gene in Myelodysplastic Syndromes
por: Hosoya, Noriko, et al.
Publicado: (1998)

Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53
por: Wang, Qian, et al.
Publicado: (2020)

Myelodysplastic Syndromes and Modalities of Treatment: An Updated Literature Review
por: Zamora, Diana I, et al.
Publicado: (2021)

When karyotype is decisive for myelodysplastic syndromes diagnosis
por: Perazzio, Aline dos Santos Borgo, et al.
Publicado: (2019)

A rare case of acquired immunodeficiency associated with myelodysplastic syndrome
por: Li, Juanjuan, et al.
Publicado: (2019)

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
por: Montalban-Bravo, Guillermo, et al.
Publicado: (2018)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
por: Wan, Ziqi, et al.
Publicado: (2020)

Low-level somatic JAK2 V617F mutation in myelodysplastic/ myeloproliferative neoplasm with ring sideroblasts, and thrombocytosis with co-mutated SF3B1 and CALR
por: Ji, Young Sok, et al.
Publicado: (2022)

Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy
por: Musto, Pellegrino, et al.
Publicado: (2014)

Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes
por: Walter, Matthew J., et al.
Publicado: (2011)

Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts
por: Martín, Iván, et al.
Publicado: (2017)

Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2020)

Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome
por: Nagehan, Pakasticali, et al.
Publicado: (2023)

WHO-defined ‘myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations
por: Patnaik, M M, et al.
Publicado: (2010)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
por: Rai, Shinya, et al.
Publicado: (2019)

A Rare Case of Essential Thrombocythemia with Coexisting JAK2 and MPL Driver Mutations
por: Jang, Mi-Ae, et al.
Publicado: (2020)

Rare Gene Mutations in Romanian Hypoacusis Patients: Case Series and a Review of the Literature
por: Neagu, Alexandra-Cristina, et al.
Publicado: (2022)

Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome
por: Jung, Seung-Hyun, et al.
Publicado: (2016)

Germline SAMD9 Mutation in Siblings with Monosomy 7 and Myelodysplastic Syndrome
por: Schwartz, Jason R., et al.
Publicado: (2017)

Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations
por: Aslan, Derya, et al.
Publicado: (2016)

Short telomere length and its correlation with gene mutations in myelodysplastic syndrome
por: Hwang, Sang Mee, et al.
Publicado: (2016)

Bioinformatics analysis of high frequency mutations in myelodysplastic syndrome-related patients
por: Wu, Kun, et al.
Publicado: (2021)

Somatic mutations predict prognosis in myelodysplastic syndrome patients with normal karyotypes
por: Zeng, Xiangzong, et al.
Publicado: (2021)

The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?
por: Cook, Michael R., et al.
Publicado: (2021)

PB1916: SOMATIC MUTATIONS ASSOCIATED WITH MYELODYSPLASTIC SYNDROME IN RUSSIAN PATIENTS
por: Kohno, A., et al.
Publicado: (2022)

Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes
por: Cristiano, Antonio, et al.
Publicado: (2023)

P743: CLINICAL OUTCOMES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SPLICEOSOME MUTATIONS
por: Urrutia, Samuel, et al.
Publicado: (2023)

EBV‐positive, HHV8‐negative large B‐cell lymphoma with an unusual germinotropic growth pattern in an immunocompetent patient
por: Asakrah, Saja K., et al.
Publicado: (2018)

Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era
por: Karlin, Kirill, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c98qs5edisiihl4hf9csash69a